×
Back to Agenda
Session 6: Key Outstanding Issues to be Resolved
Session Chair(s)
Virginia Acha
AVP, Science and Regulatory Policy, Merck & Co., Inc., United Kingdom
Speaker(s)
Esteban Herrero-Martinez, PhD
Director Regulatory Policy and Intelligence, Novartis Pharmaceuticals UK Limited, United Kingdom
Charles-Albert Helleputte
, Mayer Brown Europe, Belgium
Have an account?